Chronic Obstructive Pulmonary Disease (COPD) and emphysema are debilitating conditions that can make even simple tasks like walking or climbing stairs feel insurmountable. For many in the Texas ...
Approval of First Minimally Invasive Treatment Option in Japan that Helps Patients with Advanced Disease Breathe Easier and Have a Better Quality of Life Over 600,000 Japanese patients suffer from ...
WASHINGTON & REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pulmonx®, Inc. today announced the results of two multi-center, randomized clinical trials showing clinically meaningful improvements in lung ...
Connecticut COPD patients now have access to a new life-changing treatment in Hartford. The first patient at Saint Francis Hospital to get the procedure since it newly became available says it has ...
WHITTIER, Calif., Nov. 19, 2025 /PRNewswire/ -- PIH Health Whittier Hospital is now offering the Zephyr® Endobronchial Valve procedure, a breakthrough minimally invasive treatment option for patients ...
Chronic obstructive pulmonary disease (COPD) is among the most common lung diseases in the world. According to the World Health Organization, the lung disease is the fourth leading cause of death ...
Pulmonologists at Backus Hospital are now offering a procedure for patients with severe Chronic Obstructive Pulmonary Disease (COPD) that can greatly improve their breathing and their quality of life.
El Paso Zoo mourns death of bald eagle rescued from New Mexico The bald eagle that the El Paso Zoo was nursing back to health after it was rescued has died. Blue Angels land in El Paso, begin planning ...
COPD treatments aim to improve patients' quality of life, with options including medication, rehabilitation, and invasive procedures. Emphysema significantly impacts patients' daily activities due to ...
Pulmonx Corporation's entry into the Japan market and momentum in its Zephyr segment are potential catalysts to its market value. The company expects ~100,000 extra patient candidates from the move, ...
REDWOOD CITY, Calif. & TOKYO--(BUSINESS WIRE)--Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, announced today that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results